Summary

The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.

Brain-computer Interface System refers to an integrated hardware-software system that establishes a direct information pathway between neural activity and computers, assistive devices, rehabilitation equipment, robots, transportation systems or neuromodulation devices. Also referred to as a BCI system or brain-machine interface system, the product normally combines neural-signal electrodes or implantable interfaces, low-noise analog front ends, amplification and digital conversion modules, wired or wireless transmission, real-time preprocessing and neural-decoding software, application management software, and an external control, feedback or stimulation device. The research scope covers non-invasive systems based mainly on EEG, fNIRS or MEG; semi-invasive systems using epidural, cortical-surface or endovascular interfaces; and invasive systems using intracortical penetrating electrodes to capture spikes and local field potentials. Products range from low-channel portable headsets to high-density platforms exceeding 128 channels. Their core functions include neural-state recognition, movement-intention decoding, communication restoration, external-device control, neurofeedback, functional compensation, rehabilitation training and closed-loop neurological treatment. The market focuses on deliverable system-level products with proprietary acquisition hardware, integrated decoding functions and an identifiable interaction or feedback workflow across medical, research, consumer, industrial, transportation and specialized applications.

Key Findings
2025 global deliveries reached approximately 440,000 Brain-computer Interface Systems
Average manufacturer selling price was approximately US$1,900 per delivered system
Non-invasive systems represented the majority of global unit shipments
Medical and research applications concentrated most professional system value

Market Trends
The Brain-computer Interface System market is shifting from competition in standalone EEG amplifiers or wearable headsets toward competition in complete neural-interaction architectures. Customers increasingly assess signal-to-noise ratio, synchronization accuracy, motion-artifact suppression, preparation time, decoding latency, cross-session stability, software openness and compatibility with external equipment rather than relying on channel count alone. Non-invasive products are moving toward dry or semi-dry electrodes, wireless acquisition, compact form factors, real-time APIs and multimodal synchronization with eye tracking, EMG, motion capture, stimulation, virtual reality and robotics. Semi-invasive systems are developing along epidural, cortical-surface and endovascular routes that seek a balance between information quality, surgical complexity and long-term stability. Intracortical platforms continue to pursue higher-density neuronal recording for precise cursor, speech and robotic control, but face more demanding implantation, packaging and calibration requirements. The long-term product direction is an adaptive closed loop in which signal acquisition, decoding, device control and sensory or therapeutic feedback are continuously optimized as one system. Commercial differentiation is consequently migrating toward proprietary neural datasets, application-specific workflows, automated calibration, home-use capability and longitudinal performance rather than basic access to raw brain signals.

Market Dynamics
Drivers
Growth is being driven by converging demand from neuroscience research, neurological rehabilitation, functional compensation, assistive communication and closed-loop treatment. Universities and research institutions require configurable systems for neuro-AI, cognitive neuroscience, multimodal experiments and human-machine interaction, while hospitals need products capable of producing measurable clinical or functional outcomes for patients with spinal-cord injury, stroke, epilepsy and severe communication impairment. Improvements in flexible electrodes, low-noise analog front ends, wireless transmission, embedded computing and machine-learning decoding are making systems more portable and usable outside controlled laboratories. Policy and payment infrastructure are also beginning to move in parallel with technology. China’s brain-computer interface industrial policy identifies electrodes, dedicated chips, complete systems, standards and medical, industrial and consumer applications as priority development areas. The National Healthcare Security Administration has established service-price categories for invasive implantation, device removal and non-invasive fitting, while the NMPA approved an implantable hand-function compensation system in March 2026. These developments reduce uncertainty around clinical workflow and create a more defined transition from research projects to regulated product deployment.

Restraints
The principal restraint is the performance gap between laboratory demonstration and reliable daily use. Non-invasive EEG systems are affected by skull attenuation, electrode-contact variation, muscle and eye artefacts, head movement and environmental noise, making decoding accuracy and repeatability highly dependent on the user, task and operating environment. Additional channels may improve spatial coverage but also increase preparation time, calibration complexity, data-processing requirements and operator dependence. Semi-invasive and invasive systems carry substantially higher development and delivery costs related to biocompatible materials, microfabrication, hermetic packaging, sterile production, neurosurgery, clinical trials and long-term follow-up. Endovascular approaches must manage vascular access, anatomical limitations and antithrombotic requirements, while cortical-surface and intracortical systems face infection, tissue response, electrode migration and signal degradation risks. Medical adoption also depends on physician training, hospital capacity, reimbursement and evidence that benefits persist beyond selected clinical-study participants. These limitations create a highly uneven market in which low-cost systems can scale rapidly by volume, while high-value medical systems require long commercialization cycles and significant post-market support.

Opportunities
The most immediate opportunities lie in converting general-purpose neural acquisition platforms into validated systems for defined workflows. Home and community rehabilitation can combine portable EEG hardware, intention decoding, robotic gloves, functional electrical stimulation or exoskeletons with clinician-facing software and remote model updates. Assistive communication products can extend from cursor control to text generation, environmental control and robotic-device operation for patients with paralysis or amyotrophic lateral sclerosis. Closed-loop neurological treatment offers a separate high-value opportunity in which continuous neural monitoring triggers personalized stimulation, with epilepsy providing the most established commercial model. Consumer and enterprise products may integrate brain sensing into headphones, headbands, VR equipment, safety wearables and driver-monitoring systems, provided that measurable benefits justify continued use. Semi-invasive systems may open a clinically relevant middle path between non-invasive accessibility and intracortical information density. China’s approval of an epidural hand-function compensation system, Precision Neuroscience’s FDA-cleared cortical interface, and advancing endovascular and intracortical clinical programs indicate that multiple interface routes can coexist rather than converge on a single dominant architecture.

Challenges
Long-term market development requires technical reliability, clinical evidence, regulatory compliance and sustainable economics to be achieved simultaneously. Neural signals differ materially across users and drift over time, creating persistent challenges in model transfer, recalibration and performance validation. Implantable systems must maintain signal quality while minimizing heat, power consumption, tissue reaction, wireless-transmission failure and replacement risk. The sector also lacks fully harmonized terminology, performance benchmarks, channel-count definitions, data formats and interoperability standards, complicating product comparison and multi-centre validation. Brain data introduces additional requirements around informed consent, cybersecurity, data ownership, mental privacy and the permitted use of neural information. Commercial risk is equally important. Consumer products may show measurable neural-state signals without delivering sufficient recurring utility, while medical companies can generate high product gross margins but still incur substantial clinical, regulatory, physician-training and sales expenses. Scaling therefore depends not only on decoding accuracy but also on standard surgical procedures, application-specific evidence, reimbursement, service capacity and the ability to support patients over extended periods.

Industry Chain Analysis
The upstream Brain-computer Interface System chain consists of wet, dry and semi-dry scalp electrodes; flexible epidural and cortical electrode arrays; penetrating microelectrodes; endovascular electrode structures; conductive and biocompatible materials; hermetic packaging; low-noise amplifiers; analog front-end chips; ADCs; processors; wireless-communication and power modules; batteries; connectors; surgical tools; stimulation modules; and precision mechanical components. Upstream specifications determine signal amplitude, bandwidth, spatial resolution, channel density, noise, power consumption, thermal safety, comfort, implantation difficulty and long-term stability. Non-invasive products place greater emphasis on electrode consistency, ergonomic wearability, rapid setup and resistance to motion artefacts. Implantable products allocate more value and development expenditure to microfabrication, flexible materials, packaging reliability, sterilization, wireless power and surgical compatibility.

Midstream manufacturers integrate the neural interface, acquisition electronics, signal transmission, real-time decoding, application software and external feedback device into a deliverable system. Value creation is concentrated in reproducible signal acquisition, low-latency processing, automated calibration, cross-session model stability, integration with third-party devices and regulatory or clinical validation. Standardized low-channel hardware faces increasing price competition, shifting profit toward software licenses, development tools, validated application modules, consumables and technical services. Research-grade and medical systems retain stronger pricing power because customers require data quality, synchronization, technical support and workflow continuity. Implantable and closed-loop systems can achieve high product margins, but those margins must fund clinical trials, quality systems, regulatory submissions, surgical training and long-term patient management. Downstream customers include universities, hospitals, rehabilitation centres, neurological clinics, assistive-technology providers, consumer-electronics companies, industrial operators, transportation users and specialized government institutions.

Segment Insights
By interface type, non-invasive systems account for the majority of shipments because they offer lower risk, broader availability and shorter procurement cycles across education, research, consumer interaction and rehabilitation. Semi-invasive systems cover epidural, cortical-surface and endovascular routes that record population-level cortical activity without penetrating neural tissue. These architectures generally offer stronger and more spatially specific signals than scalp EEG while reducing some of the tissue-response risks associated with intracortical arrays. Intracortical systems record spikes and local field potentials and provide the highest potential information density for precise movement, speech and sensory decoding, but their deployment remains constrained by surgical risk, long-term signal stability and high development costs. EEG remains the dominant signal modality by unit volume, while ECoG, spikes and LFPs concentrate high-value clinical and advanced research activity. fNIRS, MEG and multimodal configurations occupy specialized research, cognitive assessment and hybrid-interface niches.

Low-channel 1–8 and 9–32-channel products dominate portable, educational, consumer and rapid-development applications. Systems in the 33–128-channel range serve advanced neuroscience, high-density EEG, brain mapping and complex multimodal experiments, while platforms above 128 channels, including 128–256-channel and higher-density configurations, support detailed cortical recording and advanced implantable research. Price and margin differences between these segments are substantial. Neuracle Technology’s prospectus reported 488 EEG acquisition systems sold in 2025 at an average tax-exclusive price of RMB159,100 per system and a 77.92% gross margin, demonstrating the economics of specialized professional equipment relative to the global weighted average price. Within applications, research and education provide the broadest established customer base, while medical rehabilitation, functional compensation and neurological treatment concentrate higher system value. Daily-life consumption, industrial control and transportation remain earlier-stage markets in which adoption depends on comfort, calibration speed and demonstrable operational benefits.

Downstream Market Opportunities
Downstream demand is becoming more application-specific. Research users require raw-data access, precise event synchronization, configurable channels and compatibility with MATLAB, Python, BCI2000, OpenViBE and multimodal laboratory equipment. Medical customers require repeatable protocols, clinical-grade reliability, therapist or physician interfaces and connectivity with robotic gloves, functional electrical stimulation, wheelchairs, prostheses and neuromodulation equipment. In rehabilitation, the commercial opportunity increasingly combines immediate functional compensation with repeated training intended to promote longer-term recovery. Closed-loop treatment customers place greater emphasis on biomarker detection, stimulation accuracy, longitudinal data and patient-management services. Daily-life and entertainment products require unobtrusive form factors and minimal calibration; industrial and transportation applications require robust state monitoring under motion, vibration and electromagnetic interference. Military and specialized government applications are more likely to focus on training, cognitive-load assessment, fatigue monitoring and complex human-machine interaction. Across these markets, suppliers able to deliver a validated end-to-end workflow rather than a generic signal stream are positioned to capture a larger proportion of downstream value.

Regional Insights
North America remains the principal high-value clinical and venture-backed development region. It contains commercially established closed-loop neurological treatment, intracortical clinical programs, endovascular systems and cortical-surface interfaces. NeuroPace provides a commercial benchmark: its RNS System generated US$81.7 million in 2025 revenue with an 81.9% product gross margin. Neuralink is conducting trials for computer and robotic-arm control, Synchron is evaluating an investigational endovascular system, Precision Neuroscience has obtained FDA clearance for its cortical interface, and Paradromics received authorization to initiate a clinical study of its fully implantable system. The region’s advantages include specialist clinical centres, regulatory experience, medical-device financing and access to software and AI capabilities, although development and patient-support costs remain high.

Europe has a strong position in research-grade EEG, neurorehabilitation, multimodal acquisition and open scientific software ecosystems, supported by companies such as g.tec, Brain Products, ANT Neuro, Bitbrain, Mentalab, mBrainTrain and Neuroelectrics. China is developing a broader manufacturing and application base spanning non-invasive research systems, rehabilitation equipment, consumer products and multiple implantable routes. The NMPA approval of an epidural Brain-computer Interface System, the establishment of medical-service price categories and expanding clinical programs have strengthened China’s position in early medical commercialization. Japan retains capabilities in fNIRS, MEG and clinical neurodiagnostic equipment, while South Korea, Taiwan and Southeast Asia remain more concentrated in research institutions, components, clinical collaboration and application development than in globally scaled system brands. Regional competition is therefore differentiated: North America leads high-value clinical innovation, Europe remains strong in research platforms, and China is accelerating full-chain localization and clinical deployment.

Competitive Landscape Analysis
The Brain-computer Interface System market has a layered competitive structure. In commercial non-invasive research and development platforms, g.tec, Brain Products, ANT Neuro, OpenBCI, Emotiv, NeuroSky, Bitbrain, Neuroelectrics, Mentalab, mBrainTrain, CGX Systems, Wearable Sensing, Compumedics Neuroscan, Neuracle Technology and BrainCo compete through signal quality, channel density, wireless performance, electrode preparation, synchronization, software openness and global research-channel coverage. InteraXon, Neurable, Neurosity and SmartCap emphasize consumer, enterprise or industrial form factors and applied neural-state interaction. In medical rehabilitation, Chinese suppliers such as BrainCo, Neuracle Technology, CUSOFT, Deayea, Entertech, HNNK, Vishee Medical, Xiangyu Medical, Medlander, Longest and other specialist developers compete through hospital access, rehabilitation-device integration and localized clinical service. The implantable and closed-loop segment is technologically fragmented: Neuralink, Paradromics and Blackrock Neurotech pursue intracortical interfaces; Precision Neuroscience focuses on cortical-surface access; Synchron uses an endovascular route; NeuroPace operates an established responsive neurostimulation business; and Neuracle Technology has commercialized an epidural functional-compensation system in China. StairMed, NeuroXess, Enlight Medical, Xinzhida, Zhirun Medical and other Chinese developers are advancing different implantable architectures and clinical pipelines. Competitive advantage increasingly depends on control of the complete stack—electrodes, acquisition chips, wireless transmission, decoding software, clinical data, regulatory evidence, external devices and long-term service. Scale in low-cost hardware alone is unlikely to establish durable leadership, while companies possessing validated workflows and proprietary longitudinal neural data can sustain stronger pricing and higher entry barriers.

Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Brain-computer Interface System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Neuralink
OpenBCI
NeuroPace
Emotiv
NeuroSky
ANT Neuro
Blackrock Neurotech
Synchron
g.tec medical engineering GmbH
Brain Products
Bitbrain
Precision Neuroscience
Paradromics
InteraXon
Neurable
Mentalab
mBrainTrain
Neuroelectrics
CGX Systems (formerly Cognionics)
Neurosity
Wearable Sensing
Compumedics Neuroscan
SmartCap(Wenco)
Shimadzu
BrainCo
Neuracle Technology
CUSOFT
Deayea
Entertech
HNNK
StairMed
NeuroXess
Enlight Medical
Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
Hanix
Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
Beijing Xinzhida Neural Technology Co., Ltd
Nanjing Vishee Medical Technology Co., Ltd.
Xiangyu Medical Co.,Ltd.
Jiangsu Apon Medical Technology Co.,Ltd.
Boling Brain Machine (Hangzhou) Technology Co., Ltd.
Medlander
Shanghai HeartCare Medical Technology Corporation Limited
Beijing Chieftain Control Engineering Technology Co., Ltd.
Kingfar International,Inc.
Suzhou Nianji Intelligent Technology Co., Ltd.
Beijing Zhiran Medical Technology Co., Ltd
Greatthink Medical Technology
Danyang Huichuang Medical Equipment Co., Ltd.
OYMotion
Aura MedTech
Casibrain
Gestala
WE-LINKING

Segment by Type
Non-Invasive
Partially Invasive
Invasive

Segment by Signal Acquisition Channel Count
1 To 8 Channels
9 To 32 Channels
33 To 128 Channels
128 To 256 Channels

Segment by Primary Signal Modality
EEG
ECoG
Spikes & LFPs
fNIRS, MEG and Others

Segment by Application
Medical Rehabilitation
Daily Life and Entertainment Consumption
Industrial Control
Traffic Driving
Research & Education
Military and Others

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Brain-computer Interface System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.

Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Brain-computer Interface System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Brain-computer Interface System Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Non-Invasive
1.2.3 Partially Invasive
1.2.4 Invasive
1.3 Market Segmentation by Signal Acquisition Channel Count
1.3.1 Global Brain-computer Interface System Market Size by Signal Acquisition Channel Count, 2021 vs 2025 vs 2032
1.3.2 1 To 8 Channels
1.3.3 9 To 32 Channels
1.3.4 33 To 128 Channels
1.3.5 128 To 256 Channels
1.4 Market Segmentation by Primary Signal Modality
1.4.1 Global Brain-computer Interface System Market Size by Primary Signal Modality, 2021 vs 2025 vs 2032
1.4.2 EEG
1.4.3 ECoG
1.4.4 Spikes & LFPs
1.4.5 fNIRS, MEG and Others
1.5 Market Segmentation by Application
1.5.1 Global Brain-computer Interface System Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Medical Rehabilitation
1.5.3 Daily Life and Entertainment Consumption
1.5.4 Industrial Control
1.5.5 Traffic Driving
1.5.6 Research & Education
1.5.7 Military and Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Brain-computer Interface System Revenue Estimates and Forecasts (2021-2032)
2.2 Global Brain-computer Interface System Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Brain-computer Interface System Sales Estimates and Forecasts (2021-2032)
2.4 Global Brain-computer Interface System Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Brain-computer Interface System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Brain-computer Interface System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Non-Invasive: Market Share by Key Manufacturers
3.5.2 Partially Invasive: Market Share by Key Manufacturers
3.5.3 Invasive: Market Share by Key Manufacturers
3.6 Global Brain-computer Interface System Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Brain-computer Interface System Sales Performance by Type
4.1.1 Global Brain-computer Interface System Sales Volume by Type (2021-2032)
4.1.2 Global Brain-computer Interface System Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Brain-computer Interface System Sales Performance by Signal Acquisition Channel Count
4.2.1 Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (2021-2032)
4.2.2 Global Brain-computer Interface System Revenue by Signal Acquisition Channel Count (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Signal Acquisition Channel Count (2021-2032)
4.3 Global Brain-computer Interface System Sales Performance by Primary Signal Modality
4.3.1 Global Brain-computer Interface System Sales Volume by Primary Signal Modality (2021-2032)
4.3.2 Global Brain-computer Interface System Revenue by Primary Signal Modality (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Primary Signal Modality (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Brain-computer Interface System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Brain-computer Interface System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Brain-computer Interface System Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Brain-computer Interface System Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Brain-computer Interface System Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Brain-computer Interface System Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Brain-computer Interface System Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Brain-computer Interface System Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Brain-computer Interface System Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Brain-computer Interface System Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Brain-computer Interface System Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Brain-computer Interface System Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Neuralink
11.1.1 Neuralink Corporation Information
11.1.2 Neuralink Business Overview
11.1.3 Neuralink Brain-computer Interface System Product Models, Descriptions and Specifications
11.1.4 Neuralink Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Neuralink Brain-computer Interface System Sales by Product in 2025
11.1.6 Neuralink Brain-computer Interface System Sales by Application in 2025
11.1.7 Neuralink Brain-computer Interface System Sales by Geographic Area in 2025
11.1.8 Neuralink Brain-computer Interface System SWOT Analysis
11.1.9 Neuralink Recent Developments
11.2 OpenBCI
11.2.1 OpenBCI Corporation Information
11.2.2 OpenBCI Business Overview
11.2.3 OpenBCI Brain-computer Interface System Product Models, Descriptions and Specifications
11.2.4 OpenBCI Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 OpenBCI Brain-computer Interface System Sales by Product in 2025
11.2.6 OpenBCI Brain-computer Interface System Sales by Application in 2025
11.2.7 OpenBCI Brain-computer Interface System Sales by Geographic Area in 2025
11.2.8 OpenBCI Brain-computer Interface System SWOT Analysis
11.2.9 OpenBCI Recent Developments
11.3 NeuroPace
11.3.1 NeuroPace Corporation Information
11.3.2 NeuroPace Business Overview
11.3.3 NeuroPace Brain-computer Interface System Product Models, Descriptions and Specifications
11.3.4 NeuroPace Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 NeuroPace Brain-computer Interface System Sales by Product in 2025
11.3.6 NeuroPace Brain-computer Interface System Sales by Application in 2025
11.3.7 NeuroPace Brain-computer Interface System Sales by Geographic Area in 2025
11.3.8 NeuroPace Brain-computer Interface System SWOT Analysis
11.3.9 NeuroPace Recent Developments
11.4 Emotiv
11.4.1 Emotiv Corporation Information
11.4.2 Emotiv Business Overview
11.4.3 Emotiv Brain-computer Interface System Product Models, Descriptions and Specifications
11.4.4 Emotiv Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Emotiv Brain-computer Interface System Sales by Product in 2025
11.4.6 Emotiv Brain-computer Interface System Sales by Application in 2025
11.4.7 Emotiv Brain-computer Interface System Sales by Geographic Area in 2025
11.4.8 Emotiv Brain-computer Interface System SWOT Analysis
11.4.9 Emotiv Recent Developments
11.5 NeuroSky
11.5.1 NeuroSky Corporation Information
11.5.2 NeuroSky Business Overview
11.5.3 NeuroSky Brain-computer Interface System Product Models, Descriptions and Specifications
11.5.4 NeuroSky Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 NeuroSky Brain-computer Interface System Sales by Product in 2025
11.5.6 NeuroSky Brain-computer Interface System Sales by Application in 2025
11.5.7 NeuroSky Brain-computer Interface System Sales by Geographic Area in 2025
11.5.8 NeuroSky Brain-computer Interface System SWOT Analysis
11.5.9 NeuroSky Recent Developments
11.6 ANT Neuro
11.6.1 ANT Neuro Corporation Information
11.6.2 ANT Neuro Business Overview
11.6.3 ANT Neuro Brain-computer Interface System Product Models, Descriptions and Specifications
11.6.4 ANT Neuro Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 ANT Neuro Recent Developments
11.7 Blackrock Neurotech
11.7.1 Blackrock Neurotech Corporation Information
11.7.2 Blackrock Neurotech Business Overview
11.7.3 Blackrock Neurotech Brain-computer Interface System Product Models, Descriptions and Specifications
11.7.4 Blackrock Neurotech Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Blackrock Neurotech Recent Developments
11.8 Synchron
11.8.1 Synchron Corporation Information
11.8.2 Synchron Business Overview
11.8.3 Synchron Brain-computer Interface System Product Models, Descriptions and Specifications
11.8.4 Synchron Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Synchron Recent Developments
11.9 g.tec medical engineering GmbH
11.9.1 g.tec medical engineering GmbH Corporation Information
11.9.2 g.tec medical engineering GmbH Business Overview
11.9.3 g.tec medical engineering GmbH Brain-computer Interface System Product Models, Descriptions and Specifications
11.9.4 g.tec medical engineering GmbH Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 g.tec medical engineering GmbH Recent Developments
11.10 Brain Products
11.10.1 Brain Products Corporation Information
11.10.2 Brain Products Business Overview
11.10.3 Brain Products Brain-computer Interface System Product Models, Descriptions and Specifications
11.10.4 Brain Products Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Brain Products Recent Developments
11.11 Bitbrain
11.11.1 Bitbrain Corporation Information
11.11.2 Bitbrain Business Overview
11.11.3 Bitbrain Brain-computer Interface System Product Models, Descriptions and Specifications
11.11.4 Bitbrain Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Bitbrain Recent Developments
11.12 Precision Neuroscience
11.12.1 Precision Neuroscience Corporation Information
11.12.2 Precision Neuroscience Business Overview
11.12.3 Precision Neuroscience Brain-computer Interface System Product Models, Descriptions and Specifications
11.12.4 Precision Neuroscience Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Precision Neuroscience Recent Developments
11.13 Paradromics
11.13.1 Paradromics Corporation Information
11.13.2 Paradromics Business Overview
11.13.3 Paradromics Brain-computer Interface System Product Models, Descriptions and Specifications
11.13.4 Paradromics Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Paradromics Recent Developments
11.14 InteraXon
11.14.1 InteraXon Corporation Information
11.14.2 InteraXon Business Overview
11.14.3 InteraXon Brain-computer Interface System Product Models, Descriptions and Specifications
11.14.4 InteraXon Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 InteraXon Recent Developments
11.15 Neurable
11.15.1 Neurable Corporation Information
11.15.2 Neurable Business Overview
11.15.3 Neurable Brain-computer Interface System Product Models, Descriptions and Specifications
11.15.4 Neurable Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Neurable Recent Developments
11.16 Mentalab
11.16.1 Mentalab Corporation Information
11.16.2 Mentalab Business Overview
11.16.3 Mentalab Brain-computer Interface System Product Models, Descriptions and Specifications
11.16.4 Mentalab Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Mentalab Recent Developments
11.17 mBrainTrain
11.17.1 mBrainTrain Corporation Information
11.17.2 mBrainTrain Business Overview
11.17.3 mBrainTrain Brain-computer Interface System Product Models, Descriptions and Specifications
11.17.4 mBrainTrain Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 mBrainTrain Recent Developments
11.18 Neuroelectrics
11.18.1 Neuroelectrics Corporation Information
11.18.2 Neuroelectrics Business Overview
11.18.3 Neuroelectrics Brain-computer Interface System Product Models, Descriptions and Specifications
11.18.4 Neuroelectrics Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Neuroelectrics Recent Developments
11.19 CGX Systems (formerly Cognionics)
11.19.1 CGX Systems (formerly Cognionics) Corporation Information
11.19.2 CGX Systems (formerly Cognionics) Business Overview
11.19.3 CGX Systems (formerly Cognionics) Brain-computer Interface System Product Models, Descriptions and Specifications
11.19.4 CGX Systems (formerly Cognionics) Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 CGX Systems (formerly Cognionics) Recent Developments
11.20 Neurosity
11.20.1 Neurosity Corporation Information
11.20.2 Neurosity Business Overview
11.20.3 Neurosity Brain-computer Interface System Product Models, Descriptions and Specifications
11.20.4 Neurosity Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Neurosity Recent Developments
11.21 Wearable Sensing
11.21.1 Wearable Sensing Corporation Information
11.21.2 Wearable Sensing Business Overview
11.21.3 Wearable Sensing Brain-computer Interface System Product Models, Descriptions and Specifications
11.21.4 Wearable Sensing Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Wearable Sensing Recent Developments
11.22 Compumedics Neuroscan
11.22.1 Compumedics Neuroscan Corporation Information
11.22.2 Compumedics Neuroscan Business Overview
11.22.3 Compumedics Neuroscan Brain-computer Interface System Product Models, Descriptions and Specifications
11.22.4 Compumedics Neuroscan Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Compumedics Neuroscan Recent Developments
11.23 SmartCap(Wenco)
11.23.1 SmartCap(Wenco) Corporation Information
11.23.2 SmartCap(Wenco) Business Overview
11.23.3 SmartCap(Wenco) Brain-computer Interface System Product Models, Descriptions and Specifications
11.23.4 SmartCap(Wenco) Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 SmartCap(Wenco) Recent Developments
11.24 Shimadzu
11.24.1 Shimadzu Corporation Information
11.24.2 Shimadzu Business Overview
11.24.3 Shimadzu Brain-computer Interface System Product Models, Descriptions and Specifications
11.24.4 Shimadzu Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Shimadzu Recent Developments
11.25 BrainCo
11.25.1 BrainCo Corporation Information
11.25.2 BrainCo Business Overview
11.25.3 BrainCo Brain-computer Interface System Product Models, Descriptions and Specifications
11.25.4 BrainCo Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 BrainCo Recent Developments
11.26 Neuracle Technology
11.26.1 Neuracle Technology Corporation Information
11.26.2 Neuracle Technology Business Overview
11.26.3 Neuracle Technology Brain-computer Interface System Product Models, Descriptions and Specifications
11.26.4 Neuracle Technology Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Neuracle Technology Recent Developments
11.27 CUSOFT
11.27.1 CUSOFT Corporation Information
11.27.2 CUSOFT Business Overview
11.27.3 CUSOFT Brain-computer Interface System Product Models, Descriptions and Specifications
11.27.4 CUSOFT Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 CUSOFT Recent Developments
11.28 Deayea
11.28.1 Deayea Corporation Information
11.28.2 Deayea Business Overview
11.28.3 Deayea Brain-computer Interface System Product Models, Descriptions and Specifications
11.28.4 Deayea Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Deayea Recent Developments
11.29 Entertech
11.29.1 Entertech Corporation Information
11.29.2 Entertech Business Overview
11.29.3 Entertech Brain-computer Interface System Product Models, Descriptions and Specifications
11.29.4 Entertech Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 Entertech Recent Developments
11.30 HNNK
11.30.1 HNNK Corporation Information
11.30.2 HNNK Business Overview
11.30.3 HNNK Brain-computer Interface System Product Models, Descriptions and Specifications
11.30.4 HNNK Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 HNNK Recent Developments
11.31 StairMed
11.31.1 StairMed Corporation Information
11.31.2 StairMed Business Overview
11.31.3 StairMed Brain-computer Interface System Product Models, Descriptions and Specifications
11.31.4 StairMed Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.31.5 StairMed Recent Developments
11.32 NeuroXess
11.32.1 NeuroXess Corporation Information
11.32.2 NeuroXess Business Overview
11.32.3 NeuroXess Brain-computer Interface System Product Models, Descriptions and Specifications
11.32.4 NeuroXess Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.32.5 NeuroXess Recent Developments
11.33 Enlight Medical
11.33.1 Enlight Medical Corporation Information
11.33.2 Enlight Medical Business Overview
11.33.3 Enlight Medical Brain-computer Interface System Product Models, Descriptions and Specifications
11.33.4 Enlight Medical Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.33.5 Enlight Medical Recent Developments
11.34 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
11.34.1 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Corporation Information
11.34.2 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Business Overview
11.34.3 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Models, Descriptions and Specifications
11.34.4 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.34.5 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments
11.35 Hanix
11.35.1 Hanix Corporation Information
11.35.2 Hanix Business Overview
11.35.3 Hanix Brain-computer Interface System Product Models, Descriptions and Specifications
11.35.4 Hanix Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.35.5 Hanix Recent Developments
11.36 Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
11.36.1 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Corporation Information
11.36.2 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Business Overview
11.36.3 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Models, Descriptions and Specifications
11.36.4 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.36.5 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments
11.37 Beijing Xinzhida Neural Technology Co., Ltd
11.37.1 Beijing Xinzhida Neural Technology Co., Ltd Corporation Information
11.37.2 Beijing Xinzhida Neural Technology Co., Ltd Business Overview
11.37.3 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Models, Descriptions and Specifications
11.37.4 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.37.5 Beijing Xinzhida Neural Technology Co., Ltd Recent Developments
11.38 Nanjing Vishee Medical Technology Co., Ltd.
11.38.1 Nanjing Vishee Medical Technology Co., Ltd. Corporation Information
11.38.2 Nanjing Vishee Medical Technology Co., Ltd. Business Overview
11.38.3 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Models, Descriptions and Specifications
11.38.4 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.38.5 Nanjing Vishee Medical Technology Co., Ltd. Recent Developments
11.39 Xiangyu Medical Co.,Ltd.
11.39.1 Xiangyu Medical Co.,Ltd. Corporation Information
11.39.2 Xiangyu Medical Co.,Ltd. Business Overview
11.39.3 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Models, Descriptions and Specifications
11.39.4 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.39.5 Xiangyu Medical Co.,Ltd. Recent Developments
11.40 Jiangsu Apon Medical Technology Co.,Ltd.
11.40.1 Jiangsu Apon Medical Technology Co.,Ltd. Corporation Information
11.40.2 Jiangsu Apon Medical Technology Co.,Ltd. Business Overview
11.40.3 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Models, Descriptions and Specifications
11.40.4 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales, Price, Revenue and Gross Margin (2021-2026)
11.40.5 Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Brain-computer Interface System Industry Chain
12.2 Brain-computer Interface System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Brain-computer Interface System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Brain-computer Interface System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Brain-computer Interface System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Brain-computer Interface System Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Brain-computer Interface System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Brain-computer Interface System Market Size Growth Rate by Signal Acquisition Channel Count, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Brain-computer Interface System Market Size Growth Rate by Primary Signal Modality, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Brain-computer Interface System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Brain-computer Interface System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Brain-computer Interface System Revenue by Region (US$ Million), 2021-2026
Table 7. Global Brain-computer Interface System Revenue by Region (US$ Million), 2027-2032
Table 8. Global Brain-computer Interface System Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Brain-computer Interface System Sales by Region (K Units), 2021-2026
Table 10. Global Brain-computer Interface System Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Brain-computer Interface System Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Brain-computer Interface System Sales Share by Manufacturers (2021-2026)
Table 14. Global Brain-computer Interface System Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Brain-computer Interface System Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Brain-computer Interface System Revenue, 2025
Table 18. Global Brain-computer Interface System Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Brain-computer Interface System Average Selling Price (ASP) by Manufacturers (K US$/Unit), 2021-2026
Table 20. Key Manufacturers Brain-computer Interface System Manufacturing Base and Headquarters
Table 21. Global Brain-computer Interface System Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Brain-computer Interface System Sales Volume by Type (K Units), 2021-2026
Table 25. Global Brain-computer Interface System Sales Volume by Type (K Units), 2027-2032
Table 26. Global Brain-computer Interface System Revenue by Type (US$ Million), 2021-2026
Table 27. Global Brain-computer Interface System Revenue by Type (US$ Million), 2027-2032
Table 28. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (K Units), 2021-2026
Table 29. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (K Units), 2027-2032
Table 30. Global Brain-computer Interface System Revenue by Signal Acquisition Channel Count (US$ Million), 2021-2026
Table 31. Global Brain-computer Interface System Revenue by Signal Acquisition Channel Count (US$ Million), 2027-2032
Table 32. Global Brain-computer Interface System Sales Volume by Primary Signal Modality (K Units), 2021-2026
Table 33. Global Brain-computer Interface System Sales Volume by Primary Signal Modality (K Units), 2027-2032
Table 34. Global Brain-computer Interface System Revenue by Primary Signal Modality (US$ Million), 2021-2026
Table 35. Global Brain-computer Interface System Revenue by Primary Signal Modality (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Brain-computer Interface System Sales by Application (K Units), 2021-2026
Table 38. Global Brain-computer Interface System Sales by Application (K Units), 2027-2032
Table 39. Brain-computer Interface System High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Brain-computer Interface System Revenue by Application (US$ Million), 2021-2026
Table 41. Global Brain-computer Interface System Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Brain-computer Interface System Growth Accelerators and Market Barriers
Table 45. North America Brain-computer Interface System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Brain-computer Interface System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Brain-computer Interface System Growth Accelerators and Market Barriers
Table 48. Europe Brain-computer Interface System Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Brain-computer Interface System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Brain-computer Interface System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Brain-computer Interface System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Brain-computer Interface System Growth Accelerators and Market Barriers
Table 53. Southeast Asia Brain-computer Interface System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Brain-computer Interface System Investment Opportunities and Key Challenges
Table 55. Central and South America Brain-computer Interface System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Brain-computer Interface System Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Brain-computer Interface System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Neuralink Corporation Information
Table 59. Neuralink Description and Major Businesses
Table 60. Neuralink Product Models, Descriptions and Specifications
Table 61. Neuralink Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 62. Neuralink Sales Value Proportion by Product in 2025
Table 63. Neuralink Sales Value Proportion by Application in 2025
Table 64. Neuralink Sales Value Proportion by Geographic Area in 2025
Table 65. Neuralink Brain-computer Interface System SWOT Analysis
Table 66. Neuralink Recent Developments
Table 67. OpenBCI Corporation Information
Table 68. OpenBCI Description and Major Businesses
Table 69. OpenBCI Product Models, Descriptions and Specifications
Table 70. OpenBCI Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 71. OpenBCI Sales Value Proportion by Product in 2025
Table 72. OpenBCI Sales Value Proportion by Application in 2025
Table 73. OpenBCI Sales Value Proportion by Geographic Area in 2025
Table 74. OpenBCI Brain-computer Interface System SWOT Analysis
Table 75. OpenBCI Recent Developments
Table 76. NeuroPace Corporation Information
Table 77. NeuroPace Description and Major Businesses
Table 78. NeuroPace Product Models, Descriptions and Specifications
Table 79. NeuroPace Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 80. NeuroPace Sales Value Proportion by Product in 2025
Table 81. NeuroPace Sales Value Proportion by Application in 2025
Table 82. NeuroPace Sales Value Proportion by Geographic Area in 2025
Table 83. NeuroPace Brain-computer Interface System SWOT Analysis
Table 84. NeuroPace Recent Developments
Table 85. Emotiv Corporation Information
Table 86. Emotiv Description and Major Businesses
Table 87. Emotiv Product Models, Descriptions and Specifications
Table 88. Emotiv Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 89. Emotiv Sales Value Proportion by Product in 2025
Table 90. Emotiv Sales Value Proportion by Application in 2025
Table 91. Emotiv Sales Value Proportion by Geographic Area in 2025
Table 92. Emotiv Brain-computer Interface System SWOT Analysis
Table 93. Emotiv Recent Developments
Table 94. NeuroSky Corporation Information
Table 95. NeuroSky Description and Major Businesses
Table 96. NeuroSky Product Models, Descriptions and Specifications
Table 97. NeuroSky Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 98. NeuroSky Sales Value Proportion by Product in 2025
Table 99. NeuroSky Sales Value Proportion by Application in 2025
Table 100. NeuroSky Sales Value Proportion by Geographic Area in 2025
Table 101. NeuroSky Brain-computer Interface System SWOT Analysis
Table 102. NeuroSky Recent Developments
Table 103. ANT Neuro Corporation Information
Table 104. ANT Neuro Description and Major Businesses
Table 105. ANT Neuro Product Models, Descriptions and Specifications
Table 106. ANT Neuro Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. ANT Neuro Recent Developments
Table 108. Blackrock Neurotech Corporation Information
Table 109. Blackrock Neurotech Description and Major Businesses
Table 110. Blackrock Neurotech Product Models, Descriptions and Specifications
Table 111. Blackrock Neurotech Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. Blackrock Neurotech Recent Developments
Table 113. Synchron Corporation Information
Table 114. Synchron Description and Major Businesses
Table 115. Synchron Product Models, Descriptions and Specifications
Table 116. Synchron Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 117. Synchron Recent Developments
Table 118. g.tec medical engineering GmbH Corporation Information
Table 119. g.tec medical engineering GmbH Description and Major Businesses
Table 120. g.tec medical engineering GmbH Product Models, Descriptions and Specifications
Table 121. g.tec medical engineering GmbH Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 122. g.tec medical engineering GmbH Recent Developments
Table 123. Brain Products Corporation Information
Table 124. Brain Products Description and Major Businesses
Table 125. Brain Products Product Models, Descriptions and Specifications
Table 126. Brain Products Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 127. Brain Products Recent Developments
Table 128. Bitbrain Corporation Information
Table 129. Bitbrain Description and Major Businesses
Table 130. Bitbrain Product Models, Descriptions and Specifications
Table 131. Bitbrain Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 132. Bitbrain Recent Developments
Table 133. Precision Neuroscience Corporation Information
Table 134. Precision Neuroscience Description and Major Businesses
Table 135. Precision Neuroscience Product Models, Descriptions and Specifications
Table 136. Precision Neuroscience Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 137. Precision Neuroscience Recent Developments
Table 138. Paradromics Corporation Information
Table 139. Paradromics Description and Major Businesses
Table 140. Paradromics Product Models, Descriptions and Specifications
Table 141. Paradromics Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 142. Paradromics Recent Developments
Table 143. InteraXon Corporation Information
Table 144. InteraXon Description and Major Businesses
Table 145. InteraXon Product Models, Descriptions and Specifications
Table 146. InteraXon Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 147. InteraXon Recent Developments
Table 148. Neurable Corporation Information
Table 149. Neurable Description and Major Businesses
Table 150. Neurable Product Models, Descriptions and Specifications
Table 151. Neurable Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 152. Neurable Recent Developments
Table 153. Mentalab Corporation Information
Table 154. Mentalab Description and Major Businesses
Table 155. Mentalab Product Models, Descriptions and Specifications
Table 156. Mentalab Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 157. Mentalab Recent Developments
Table 158. mBrainTrain Corporation Information
Table 159. mBrainTrain Description and Major Businesses
Table 160. mBrainTrain Product Models, Descriptions and Specifications
Table 161. mBrainTrain Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 162. mBrainTrain Recent Developments
Table 163. Neuroelectrics Corporation Information
Table 164. Neuroelectrics Description and Major Businesses
Table 165. Neuroelectrics Product Models, Descriptions and Specifications
Table 166. Neuroelectrics Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 167. Neuroelectrics Recent Developments
Table 168. CGX Systems (formerly Cognionics) Corporation Information
Table 169. CGX Systems (formerly Cognionics) Description and Major Businesses
Table 170. CGX Systems (formerly Cognionics) Product Models, Descriptions and Specifications
Table 171. CGX Systems (formerly Cognionics) Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 172. CGX Systems (formerly Cognionics) Recent Developments
Table 173. Neurosity Corporation Information
Table 174. Neurosity Description and Major Businesses
Table 175. Neurosity Product Models, Descriptions and Specifications
Table 176. Neurosity Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 177. Neurosity Recent Developments
Table 178. Wearable Sensing Corporation Information
Table 179. Wearable Sensing Description and Major Businesses
Table 180. Wearable Sensing Product Models, Descriptions and Specifications
Table 181. Wearable Sensing Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 182. Wearable Sensing Recent Developments
Table 183. Compumedics Neuroscan Corporation Information
Table 184. Compumedics Neuroscan Description and Major Businesses
Table 185. Compumedics Neuroscan Product Models, Descriptions and Specifications
Table 186. Compumedics Neuroscan Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 187. Compumedics Neuroscan Recent Developments
Table 188. SmartCap(Wenco) Corporation Information
Table 189. SmartCap(Wenco) Description and Major Businesses
Table 190. SmartCap(Wenco) Product Models, Descriptions and Specifications
Table 191. SmartCap(Wenco) Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 192. SmartCap(Wenco) Recent Developments
Table 193. Shimadzu Corporation Information
Table 194. Shimadzu Description and Major Businesses
Table 195. Shimadzu Product Models, Descriptions and Specifications
Table 196. Shimadzu Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 197. Shimadzu Recent Developments
Table 198. BrainCo Corporation Information
Table 199. BrainCo Description and Major Businesses
Table 200. BrainCo Product Models, Descriptions and Specifications
Table 201. BrainCo Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 202. BrainCo Recent Developments
Table 203. Neuracle Technology Corporation Information
Table 204. Neuracle Technology Description and Major Businesses
Table 205. Neuracle Technology Product Models, Descriptions and Specifications
Table 206. Neuracle Technology Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 207. Neuracle Technology Recent Developments
Table 208. CUSOFT Corporation Information
Table 209. CUSOFT Description and Major Businesses
Table 210. CUSOFT Product Models, Descriptions and Specifications
Table 211. CUSOFT Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 212. CUSOFT Recent Developments
Table 213. Deayea Corporation Information
Table 214. Deayea Description and Major Businesses
Table 215. Deayea Product Models, Descriptions and Specifications
Table 216. Deayea Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 217. Deayea Recent Developments
Table 218. Entertech Corporation Information
Table 219. Entertech Description and Major Businesses
Table 220. Entertech Product Models, Descriptions and Specifications
Table 221. Entertech Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 222. Entertech Recent Developments
Table 223. HNNK Corporation Information
Table 224. HNNK Description and Major Businesses
Table 225. HNNK Product Models, Descriptions and Specifications
Table 226. HNNK Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 227. HNNK Recent Developments
Table 228. StairMed Corporation Information
Table 229. StairMed Description and Major Businesses
Table 230. StairMed Product Models, Descriptions and Specifications
Table 231. StairMed Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 232. StairMed Recent Developments
Table 233. NeuroXess Corporation Information
Table 234. NeuroXess Description and Major Businesses
Table 235. NeuroXess Product Models, Descriptions and Specifications
Table 236. NeuroXess Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 237. NeuroXess Recent Developments
Table 238. Enlight Medical Corporation Information
Table 239. Enlight Medical Description and Major Businesses
Table 240. Enlight Medical Product Models, Descriptions and Specifications
Table 241. Enlight Medical Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 242. Enlight Medical Recent Developments
Table 243. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Corporation Information
Table 244. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Description and Major Businesses
Table 245. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 246. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 247. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments
Table 248. Hanix Corporation Information
Table 249. Hanix Description and Major Businesses
Table 250. Hanix Product Models, Descriptions and Specifications
Table 251. Hanix Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 252. Hanix Recent Developments
Table 253. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Corporation Information
Table 254. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Description and Major Businesses
Table 255. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 256. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 257. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments
Table 258. Beijing Xinzhida Neural Technology Co., Ltd Corporation Information
Table 259. Beijing Xinzhida Neural Technology Co., Ltd Description and Major Businesses
Table 260. Beijing Xinzhida Neural Technology Co., Ltd Product Models, Descriptions and Specifications
Table 261. Beijing Xinzhida Neural Technology Co., Ltd Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 262. Beijing Xinzhida Neural Technology Co., Ltd Recent Developments
Table 263. Nanjing Vishee Medical Technology Co., Ltd. Corporation Information
Table 264. Nanjing Vishee Medical Technology Co., Ltd. Description and Major Businesses
Table 265. Nanjing Vishee Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 266. Nanjing Vishee Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 267. Nanjing Vishee Medical Technology Co., Ltd. Recent Developments
Table 268. Xiangyu Medical Co.,Ltd. Corporation Information
Table 269. Xiangyu Medical Co.,Ltd. Description and Major Businesses
Table 270. Xiangyu Medical Co.,Ltd. Product Models, Descriptions and Specifications
Table 271. Xiangyu Medical Co.,Ltd. Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 272. Xiangyu Medical Co.,Ltd. Recent Developments
Table 273. Jiangsu Apon Medical Technology Co.,Ltd. Corporation Information
Table 274. Jiangsu Apon Medical Technology Co.,Ltd. Description and Major Businesses
Table 275. Jiangsu Apon Medical Technology Co.,Ltd. Product Models, Descriptions and Specifications
Table 276. Jiangsu Apon Medical Technology Co.,Ltd. Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 277. Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments
Table 278. Key Raw Materials Distribution
Table 279. Raw Materials Key Suppliers
Table 280. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 281. Milestones in Production Technology Evolution
Table 282. Distributors List
Table 283. Market Trends and Market Evolution
Table 284. Market Drivers and Opportunities
Table 285. Market Challenges, Risks, and Restraints
Table 286. Research Programs/Design for This Report
Table 287. Key Data Information from Secondary Sources
Table 288. Key Data Information from Primary Sources

List of Figures
Figure 1. Brain-computer Interface System Product Picture
Figure 2. Global Brain-computer Interface System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Non-Invasive Product Picture
Figure 4. Partially Invasive Product Picture
Figure 5. Invasive Product Picture
Figure 6. Global Brain-computer Interface System Market Size Growth Rate by Signal Acquisition Channel Count, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. 1 To 8 Channels Product Picture
Figure 8. 9 To 32 Channels Product Picture
Figure 9. 33 To 128 Channels Product Picture
Figure 10. 128 To 256 Channels Product Picture
Figure 11. Global Brain-computer Interface System Market Size Growth Rate by Primary Signal Modality, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. EEG Product Picture
Figure 13. ECoG Product Picture
Figure 14. Spikes & LFPs Product Picture
Figure 15. fNIRS, MEG and Others Product Picture
Figure 16. Global Brain-computer Interface System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Medical Rehabilitation
Figure 18. Daily Life and Entertainment Consumption
Figure 19. Industrial Control
Figure 20. Traffic Driving
Figure 21. Research & Education
Figure 22. Military and Others
Figure 23. Brain-computer Interface System Report Years Considered
Figure 24. Global Brain-computer Interface System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 26. Global Brain-computer Interface System Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 27. Global Brain-computer Interface System Revenue-Based Market Share by Region (2021-2032)
Figure 28. Global Brain-computer Interface System Sales (K Units), 2021-2032
Figure 29. Global Brain-computer Interface System Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 30. Global Brain-computer Interface System Sales Market Share by Region (2021-2032)
Figure 31. Top 5 and Top 10 Manufacturers Brain-computer Interface System Sales Volume Market Share in 2025
Figure 32. Global Brain-computer Interface System Revenue-Based Market Share Ranking (2025)
Figure 33. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 34. Non-Invasive Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Partially Invasive Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Invasive Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Global Brain-computer Interface System Sales Volume-Based Market Share by Type (2021-2032)
Figure 38. Global Brain-computer Interface System Revenue-Based Market Share by Type (2021-2032)
Figure 39. Global Brain-computer Interface System ASP by Type (K US$/Unit), 2021-2032
Figure 40. Global Brain-computer Interface System Sales Volume-Based Market Share by Signal Acquisition Channel Count (2021-2032)
Figure 41. Global Brain-computer Interface System Revenue-Based Market Share by Signal Acquisition Channel Count (2021-2032)
Figure 42. Global Brain-computer Interface System ASP by Signal Acquisition Channel Count (K US$/Unit), 2021-2032
Figure 43. Global Brain-computer Interface System Sales Volume-Based Market Share by Primary Signal Modality (2021-2032)
Figure 44. Global Brain-computer Interface System Revenue-Based Market Share by Primary Signal Modality (2021-2032)
Figure 45. Global Brain-computer Interface System ASP by Primary Signal Modality (K US$/Unit), 2021-2032
Figure 46. Global Brain-computer Interface System Sales Market Share by Application (2021-2032)
Figure 47. Global Brain-computer Interface System Revenue-Based Market Share by Application (2021-2032)
Figure 48. Global Brain-computer Interface System ASP by Application (K US$/Unit), 2021-2032
Figure 49. North America Brain-computer Interface System Sales YoY (K Units), 2021-2032
Figure 50. North America Brain-computer Interface System Revenue YoY (US$ Million), 2021-2032
Figure 51. North America Top 5 Manufacturers Brain-computer Interface System Sales Revenue (US$ Million) in 2025
Figure 52. North America Brain-computer Interface System Sales Volume (K Units) by Application (2021-2032)
Figure 53. North America Brain-computer Interface System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 54. US Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 55. Canada Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 56. Mexico Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 57. Europe Brain-computer Interface System Sales YoY (K Units), 2021-2032
Figure 58. Europe Brain-computer Interface System Revenue YoY (US$ Million), 2021-2032
Figure 59. Europe Top 5 Manufacturers Brain-computer Interface System Sales Revenue (US$ Million) in 2025
Figure 60. Europe Brain-computer Interface System Sales Volume (K Units) by Application (2021-2032)
Figure 61. Europe Brain-computer Interface System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 62. Germany Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 63. France Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 64. U.K. Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 65. Italy Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 66. Russia Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 67. Asia-Pacific Brain-computer Interface System Sales YoY (K Units), 2021-2032
Figure 68. Asia-Pacific Brain-computer Interface System Revenue YoY (US$ Million), 2021-2032
Figure 69. Asia-Pacific Top 8 Manufacturers Brain-computer Interface System Sales Revenue (US$ Million) in 2025
Figure 70. Asia-Pacific Brain-computer Interface System Sales Volume (K Units) by Application (2021-2032)
Figure 71. Asia-Pacific Brain-computer Interface System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 72. Indonesia Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 73. Japan Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 74. South Korea Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 75. China Taiwan Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 76. India Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 77. Central and South America Brain-computer Interface System Sales YoY (K Units), 2021-2032
Figure 78. Central and South America Brain-computer Interface System Revenue YoY (US$ Million), 2021-2032
Figure 79. Central and South America Top 5 Manufacturers Brain-computer Interface System Sales Revenue (US$ Million) in 2025
Figure 80. Central and South America Brain-computer Interface System Sales Volume (K Units) by Application (2021-2032)
Figure 81. Central and South America Brain-computer Interface System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 82. Brazil Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 83. Argentina Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 84. Middle East, and Africa Brain-computer Interface System Sales YoY (K Units), 2021-2032
Figure 85. Middle East and Africa Brain-computer Interface System Revenue YoY (US$ Million), 2021-2032
Figure 86. Middle East and Africa Top 5 Manufacturers Brain-computer Interface System Sales Revenue (US$ Million) in 2025
Figure 87. Middle East and Africa Brain-computer Interface System Sales Volume (K Units) by Application (2021-2032)
Figure 88. Middle East and Africa Brain-computer Interface System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 89. GCC Countries Brain-computer Interface System Revenue (US$ Million), 2021-2032
Figure 90. Turkey Brain-computer Interface System Revenue (US$ Million), 2021-2032